Global Radiation Therapy Market – Analysis By Product Type (External Beam RT, Internal Beam RT), By Application, By End User, By Region, By Country (2020 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2020-2025)
Executive Summary The global radiation therapy market was valued at USD 5216.04 million in the year 2019, according to a research report published in June 2020. The growth of the radiation therapy market will primarily be supported by an Increasing public health spending as cancer is the second most deadly disease in the world, coupled with governments in different countries focusing on improving health facilities to lower cancer mortality rates, which will boost market growth over the forecast period. United States holds the highest proportion of radiation therapy facilities per million patients globally whereas China has the lowest proportion of radiation therapy facility installations among developing nations, as the country has less than 1 facility per million patients. Hence, the developing economies of the world like India and China holds immense market potential for radiation therapy as there is an acute shortage of radiation therapy centers in the Asia Pacific region.
Under the product segment, External-Beam Radiation Therapy is anticipated to witness the largest market share owing to ever increasing cases of Lung cancer, Breast cancer and low cost of cancer treatment by radiation therapy, various companies are focusing on research and development in order to offer better treatment to cancer patients, which will accelerate the Global Radiation Therapy market growth in the coming years. Hospitals and others followed by clinics attained substantial market share chiefly on the back of growing collaborations or partnership with leading manufacturers with clinics, doctors, surgeons, and hospitals in order to better understand the requirements of consumers and provide them the desired products backed with rising adoption of Radiation Therapy with escalating number of breast cancer cases. Among the regions, EMEA, followed by Americas and Asia Pacific, will experience remarkable market share owing to presence of leading Radiation therapy equipment manufacturers in the region which are constantly engaged in meeting consumers’ demands coupled with growing awareness among people regarding cancer. These factors will be propelling the Radiation Therapy market growth during the period of 2020-2025.
Scope of the Report • The report analyses Radiation Therapy market market By Value. • The report analyses Radiation Therapy market By Product Type (External-Beam Radiation Therapy, Internal-Beam Radiation Therapy). • The report assesses the Radiation Therapy market By Application (Lung cancer, Breast Cancer, Colorectal cancer, Others). • The report assesses the Radiation Therapy market By End User (Hospitals & Others, Clinics). • The Global Radiation Therapy Market has been analysed By Region (Americas, EMEA, and Asia Pacific) and By Country (United States, Canada, Mexico, Germany, France, United Kingdom, Italy, China, Japan, India). • The key insights of the report have been presented through the frameworks of mergers and acquisitions and presence of companies in Radiation Therapy market. Market share of leading Radiation Therapy manufactures has also been included in the report. Also, the attractiveness of the market has been presented By Region, Product Type, Application Type and End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report. • The report tracks competitive developments, mergers and acquisitions in Radiation Therapy Market. The companies analysed in the report include Varian Medical System Inc., Elekta AB, Accuray Inc., ViewRay Inc., C. R. Bard Inc., Isoay Inc., Mevion Inc., Optivus Proton Therapy, Hitachi Corporation, Panacea Medical Technologies. • The report presents the analysis of Radiation Therapy market for the historical period of 2015-2019 and the forecast period of 2020-2025.
The US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period. The growth of this market is mainly attributed to the growing prevalence of cancer, rise in chronic diseases, increased investment in health facilities, technological...
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
The gastrointestinal stent market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6 % during the forecast period of 2021 to 2026. Gastrointestinal (GI) stents are designed for palliative therapy for various diseases causing obstruction in the GI tract.GI stents have a major role in the recanalization...
Wearable Injectors Market By Type (On-Body and Off-Body), Usage (Disposable and Semi-Reusable), Technology (Electronic, Mechanical, and Others), Mechanism Of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Disease,...
Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Proton therapy is a type of radiation called proton beam radiation therapy it is safer and more effective than conventional radiation therapy for adults with advanced stages cancer. Since,...
The global flow cytometry market size is projected to reach USD 6.3 billion by 2026 from USD 4.3 billion in 2021, growing at a CAGR of 8.1% from 2020 to 2026. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing...
The apheresis market was valued at approximately USD 1,639 million in 2020, and it is expected to witness a revenue of USD 2580 million in 2026, with a CAGR of 7.85% over the forecast period, 2021-2026. The apheresis market is expected to be positively impacted during the COVID-19 pandemic owing to the extensive application of plasma...
The global nuclear medicine market is projected to reach USD 7.5 billion by 2026 from USD 4.8billion in 2021, at a CAGR of 9.0% during the forecast period. Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
histopathology services market was valued at US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations...
Healthcare
Biopsy
Cancer
Infectious Disease
World
Europe
APAC
Cancer Incidence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.